The drug Molnupiravir is used for patients with at least one risk factor. It blocks an enzyme that the virus needs to reproduce the genetic code.
The anti-covid drug Molnupiravir was purchased at the expense of the state budget. The international organization Crown Agents has already transferred 50,000 courses to Ukraine. Another 110,000 courses will arrive in the country by the end of May. This was reported by the Ministry of Health on May 18.
“Despite the war, we also need to take care of patients with covid. So, we thank the Crown Agents for their cooperation and immediate provision of medicines. The first supply of medicine has already been distributed to the regions and will start to grow delivered to health care facilities in the near future, ”said First Deputy Minister of Health Alexander Komarida.
Molnupiravir is a direct -acting drug. This blocks the enzyme the virus needs to reproduce the genetic code, and thus prevents the virus from replicating and reduces the risk of a serious course of the disease. In the world, this drug is used for patients with at least one risk factor, for example: overweight, age over 60 years, diabetes mellitus, heart disease.
In Ukraine, the drug will also be used to treat at -risk patients.
Recall that the earlier Ukrainian scientists discovered a new property antiviral drug remdesivir, originally developed for the treatment of hepatitis C and used together with other drugs for the treatment of coronavirus infection COVID- 19.
News from Athletistic in the Telegram. Subscribe to our channel Athletistic
Source: korrespondent
